Journal of Prostate Cancer
Open Access
Docetaxel
Search results for
Docetaxel
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
Useful Links
Related Subjects
Share This Page
Docetaxel
Docetaxel is an anti-neoplastic chemotherapy drug, classified as a "plant alkaloid," a "taxane" and an "antimicrotubule agent." It may cause low levels of white blood cells in the blood. It can be treated for locally metastatic breast cancer, gastric cancer, hormone-refractory prostate cancer and non small-cell lung cancer.
Low white blood count: Decrease in white blood count(increase the risk of infection ) Low red blood count: Decrease in red blood count(anemia) Nausea: Feeling of need to vomit Mouth sores: Inflammatory reaction from mouth to stomach Peripheral neuropathy : Feeling of Numbness in feet and legs
Related Journals of Docetaxel
Journal of Prostate Cancer, Journal of Cancer Science & Therapy, The new england journal of medicine, Europeanurology